Stock OPTI OPTIMI HEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Optimi Health Corp.

Equities

OPTI

CA68405H1001

Market Closed - Canadian Securities Exchange
Other stock markets
 03:59:22 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.34 CAD -2.86% Intraday chart for Optimi Health Corp. +28.30% +38.78%
Apr. 15 Optimi Health Corp. Completes In-House Production of MDMA Active Pharmaceutical Ingredient CI
Apr. 09 Optimi Health Corp. Signs Psilocybin Supply Agreement with Matai Medical Research Institute CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
GL
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
GL
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
AQ
Optimi Health Corp. Completes In-House Production of MDMA Active Pharmaceutical Ingredient
CI
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
GL
Optimi Health Corp. Signs Psilocybin Supply Agreement with Matai Medical Research Institute
CI
Early Warning Press Release in Accordance with National Instrument 62-103
NE
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
GL
Optimi Health Corp. Receives Finished Product Test Results and Certificate of Analysis for GMP Natural Psilocybin Extract
CI
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
GL
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
AQ
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
MT
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
GL
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
CI
Optimi Health Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Optimi Announces Closing of First Tranche of Non-Brokered Private Placement
GL
492,000 Warrants of Optimi Health Corp. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.
CI
606,000 Options of Optimi Health Corp. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.
CI
3,048,000 Common Share of Optimi Health Corp. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.
CI
Optimi Health Notes Lykos Therapeutics and FDA Priority Review of New Drug Application
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPTI Stock
  4. News Optimi Health Corp.